{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:40Z","timestamp":1760852380659,"version":"3.37.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1124\/jpet.109.160663","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T04:59:26Z","timestamp":1259125166000},"page":"840-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["The Molecular Pharmacology and In Vivo Activity of 2-(4-Chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a Dual Inhibitor of Microsomal Prostaglandin E2 Synthase-1 and 5-Lipoxygenase"],"prefix":"10.1016","volume":"332","author":[{"given":"Andreas","family":"Koeberle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Dehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Reckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Hoernig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinnak","family":"Northoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"D\u00f6tsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Sautebin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Schubert-Zsilavecz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.160663_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/ci700315c","article-title":"Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure-activity correlation","volume":"48","author":"AbdulHameed","year":"2008","journal-title":"J Chem Inf Model"},{"key":"10.1124\/jpet.109.160663_bib2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0006-2952(02)01387-4","article-title":"Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase","volume":"64","author":"Albert","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.109.160663_bib3","doi-asserted-by":"crossref","first-page":"22057","DOI":"10.1074\/jbc.M402828200","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1\u03b2-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1","volume":"279","author":"Cheng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160663_bib4","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.bmcl.2007.10.033","article-title":"Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors","volume":"17","author":"C\u00f4t\u00e9","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.109.160663_bib5","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00018-009-0078-3","article-title":"Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo","volume":"66","author":"Feisst","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/jpet.109.160663_bib6","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1021\/jm800197b","article-title":"Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target","volume":"51","author":"Friesen","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.109.160663_bib7","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1124\/jpet.109.160663_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/jm700952v","article-title":"Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors","volume":"51","author":"Giannetti","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.109.160663_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/BJ20050964","article-title":"Peroxisome-proliferator-activated receptor \u03b1 agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1","volume":"395","author":"Grau","year":"2006","journal-title":"Biochem J"},{"key":"10.1124\/jpet.109.160663_bib10","doi-asserted-by":"crossref","first-page":"28028","DOI":"10.1074\/jbc.M001387200","article-title":"Feedback control of cyclooxygenase-2 expression through PPAR\u03b3","volume":"275","author":"Inoue","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160663_bib11","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1073\/pnas.0802894105","article-title":"Structural basis for induced formation of the inflammatory mediator prostaglandin E2","volume":"105","author":"Jegersch\u00f6ld","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160663_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-1759(96)00195-0","article-title":"Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors","volume":"200","author":"Karlsson","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1124\/jpet.109.160663_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/jm00381a005","article-title":"Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of \u03c9-pyridylalkenoic acids","volume":"28","author":"Kato","year":"1985","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.109.160663_bib14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bcp.2009.02.005","article-title":"Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol","volume":"77","author":"Koeberle","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.109.160663_bib15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1476-5381.2009.00070.x","article-title":"Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E2 synthase-1","volume":"156","author":"Koeberle","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.109.160663_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.108.139444","article-title":"Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1","volume":"326","author":"Koeberle","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.160663_bib17","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.2174\/092986709789578178","article-title":"Inhibitors of the microsomal prostaglandin E2 synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)\u2014a critical review","volume":"16","author":"Koeberle","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.109.160663_bib18","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1021\/jm801085s","article-title":"Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase","volume":"51","author":"Koeberle","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.109.160663_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/156802607779941341","article-title":"Dual acting anti-inflammatory drugs","volume":"7","author":"Leone","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/jpet.109.160663_bib20","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1074\/jbc.M006865200","article-title":"Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis","volume":"276","author":"Mancini","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160663_bib21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"10.1124\/jpet.109.160663_bib22","doi-asserted-by":"crossref","first-page":"32783","DOI":"10.1074\/jbc.M003505200","article-title":"Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2","volume":"275","author":"Murakami","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160663_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1046-5928(02)00566-1","article-title":"Purification and characterization of recombinant microsomal prostaglandin E synthase-1","volume":"26","author":"Ouellet","year":"2002","journal-title":"Protein Expr Purif"},{"key":"10.1124\/jpet.109.160663_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0006-2952(02)00844-4","article-title":"Inhibition of inducible prostaglandin E2 synthase by 15-deoxy-\u0394(12,14)-prostaglandin J2 and polyunsaturated fatty acids","volume":"63","author":"Quraishi","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.109.160663_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/1-4020-5688-5_1","article-title":"Anti-inflammatory drugs in the 21st century","volume":"42","author":"Rainsford","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1124\/jpet.109.160663_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ardp.200700209","article-title":"\u03b1-Alkyl substituted pirinixic acid derivatives as potent dual agonists of the peroxisome proliferator activated receptor \u03b1 and \u03b3","volume":"341","author":"Rau","year":"2008","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1124\/jpet.109.160663_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/abio.2001.5314","article-title":"High-resolution and high-throughput protocols for measuring drug\/human serum albumin interactions using BIACORE","volume":"296","author":"Rich","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.109.160663_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jmr.928","article-title":"Survey of the year 2007 commercial optical biosensor literature","volume":"21","author":"Rich","year":"2008","journal-title":"J Mol Recognit"},{"key":"10.1124\/jpet.109.160663_bib29","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.bmcl.2005.05.027","article-title":"Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886","volume":"15","author":"Riendeau","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.109.160663_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0022-3565(24)38776-2","article-title":"Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2","volume":"296","author":"Riendeau","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.160663_bib31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1006\/bbrc.1996.1297","article-title":"Global analysis of a macromolecular interaction measured on BIAcore","volume":"225","author":"Roden","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.109.160663_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.108.143214","article-title":"Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo","volume":"329","author":"Rossi","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.160663_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.109.160663_bib34","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1038\/nprot.2007.426","article-title":"Preparative scale expression of membrane proteins in Escherichia coli-based continuous exchange cell-free systems","volume":"2","author":"Schwarz","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1124\/jpet.109.160663_bib35","doi-asserted-by":"crossref","first-page":"22199","DOI":"10.1074\/jbc.M303227200","article-title":"Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination","volume":"278","author":"Thor\u00e9n","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160663_bib36","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1332766100","article-title":"Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase","volume":"100","author":"Trebino","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160663_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2796.2008.01938.x","article-title":"Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease","volume":"263","author":"Wang","year":"2008","journal-title":"J Intern Med"},{"key":"10.1124\/jpet.109.160663_bib38","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/jm800588x","article-title":"Novel and potent inhibitors of 5-lipoxygenase product synthesis based on the structure of pirinixic acid","volume":"51","author":"Werz","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.109.160663_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/jpet.108.138776","article-title":"MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)isophthalonitrile], a selective microsomal prostaglandin E synthase 1 inhibitor, relieves pyresis and pain in preclinical models of inflammation","volume":"326","author":"Xu","year":"2008","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524456954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524456954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.160663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:06:57Z","timestamp":1740017217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524456954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0022356524456954"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.160663","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Molecular Pharmacology and In Vivo Activity of 2-(4-Chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a Dual Inhibitor of Microsomal Prostaglandin E2 Synthase-1 and 5-Lipoxygenase","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.160663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}